Cardiovascular complications are the leading cause of death in patients tre
ated with dialysis over a long period. Cardiac death does not only result f
rom coronary arteries, but also from a specific uremic cardiomyopathy. Myoc
ardial structure shows hypertrophy of myocytes, interstitial myocardial fib
rosis, reduction of capillary supply and damage of small arteries. Similar
alterations are regularly found in arterial hypertension without impaired r
enal function. Experimental and retrospective autoptic investigations estab
lished renal insufficiency as determinant of the myocardial anomalies indep
endent on hypertension. It is suggested that the renin-angiotensin-system,
parathormone and the endothelin-system are involved in the pathogenesis of
uremic heart disease. With respect to cardioprotection in renal failure opt
imal therapy is likely to be different to patients with arterial hypertensi
on and normal renal function.